US EditionPublished • loading... • Updated
Planned Parenthood expands gender drug business by 40% even as evidence of harm mounts
Summary by ifamnews.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Planned Parenthood expands gender drug business by 40% even as evidence of harm mounts
A new report from the Concerned Women for America Legislative Action Committee reveals that Planned Parenthood dramatically expanded its cross-sex hormone business in 2025, with a 40% surge in so-called "gender-affirming" drug sales at 14 of its largest affiliates — even as public opposition grows and multiple countries move to ban such interventions for minors.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
